India proposes price regulation for patented drugs

02/27/2013 | Economic Times (India), The

A government panel in India has recommended that prices for expensive drugs to treat critical diseases like HIV, cancer and hepatitis be based on the nation's per capita income, which could substantially reduce their costs and make them more affordable for patients. Some in the industry warn, however, that the regulations could backfire and instead prevent companies from offering new drugs in India.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC